Celsion CORP Sample Contracts

SERIES DDD COMMON STOCK PURCHASE WARRANT
Common Stock Purchase Warrant • November 14th, 2017 • Celsion CORP • Pharmaceutical preparations

THIS SERIES DDD COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ ], 2018 (the “Initial Exercise Date”) and on or prior to the close of business on [ ], 2019 (the “Termination Date”, provided, however, that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day) but not thereafter, to subscribe for and purchase from Celsion Corporation, a Delaware corporation (the “Company”), up to [ ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

AutoNDA by SimpleDocs
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 9th, 2024 • Imunon, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of [•], 2024, between Imunon, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

and
Rights Agreement • August 21st, 2002 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Delaware
SECTION 1 - DEFINITIONS
License Agreement • December 13th, 1996 • Cheung Laboratories Inc • Electromedical & electrotherapeutic apparatus • New York
AMENDMENT NO. 1 TO RIGHTS AGREEMENT DATED AS OF AUGUST 15, 2002
Rights Agreement • June 14th, 2004 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Delaware
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT celsion corporation
Security Agreement • July 11th, 2017 • Celsion CORP • Pharmaceutical preparations

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January [ ], 2018 (the “Initial Exercise Date”) and on or prior to the close of business on [ ] (the “Termination Date”), provided, however, that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day, but not thereafter, to subscribe for and purchase from Celsion Corporation, a Delaware corporation (the “Company”), up to [ ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

M.H. MEYERSON & CO., INC. FOUNDED 1960 BROKER & DEALER IN SECURITIES UNDERWRITERS
Agreement • July 6th, 2001 • Celsion Corp • Electromedical & electrotherapeutic apparatus • New Jersey
301650.001(BF) 1
Consulting Agreement • December 12th, 1996 • Cheung Laboratories Inc • Electromedical & electrotherapeutic apparatus • Illinois
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 3rd, 2020 • Celsion CORP • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of February 27, 2020, between Celsion Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

AMENDMENT NO. 1 TO RIGHTS AGREEMENT DATED AS OF AUGUST 15, 2002
Rights Agreement • June 14th, 2004 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Delaware
WITNESSETH:
Executive Employment Agreement • December 28th, 2001 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
WARRANT TO PURCHASE SHARES OF COMMON STOCK Imunon, INC.
Warrant Agreement • July 31st, 2024 • Imunon, Inc. • Pharmaceutical preparations

THIS WARRANT TO PURCHASE SHARES OF COMMON STOCK (the “Warrant”) certifies that, for value received, _____ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on __ , 20301 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Imunon, Inc., a Delaware corporation (the “Company”), up to ___ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

CELSION CORPORATION Up to $25,000,000 of Shares of Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales Agreement
Sales Agreement • February 1st, 2013 • Celsion CORP • Pharmaceutical preparations • New York

Celsion Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:

WITNESSETH:
Executive Employment Agreement • December 14th, 2000 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
AutoNDA by SimpleDocs
COMMON STOCK PURCHASE WARRANT Celsion Corporation
Common Stock Purchase Warrant • March 13th, 2020 • Celsion CORP • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_________________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August 10, 2020 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on August 10, 2025 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Celsion Corporation, a Delaware corporation (the “Company”), up to [__________] shares of common stock, par value $0.01 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON STOCK PURCHASE WARRANT CELSION CORPORATION
Common Stock Purchase Warrant • February 26th, 2013 • Celsion CORP • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Celsion Corporation, a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

RECITALS
Letter of Intent • December 13th, 1996 • Cheung Laboratories Inc • Electromedical & electrotherapeutic apparatus • Maryland
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 7th, 2022 • Celsion CORP • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April 6, 2022, between Celsion Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

PURCHASE AGREEMENT
Purchase Agreement • September 8th, 2020 • Celsion CORP • Pharmaceutical preparations • Illinois

THIS PURCHASE AGREEMENT (the “Agreement”), dated as of September 8, 2020, by and between CELSION CORPORATION, a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”). Capitalized terms used herein and not otherwise defined herein are defined in Section 1 hereof.

AGREEMENT ---------
Retirement Agreement • August 28th, 2003 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Maryland
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • July 31st, 2024 • Imunon, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of July 30, 2024, between Imunon, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

BETWEEN
Transaction Agreement • January 22nd, 2003 • Celsion Corp • Electromedical & electrotherapeutic apparatus • Delaware
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • December 6th, 2011 • Celsion CORP • Pharmaceutical preparations • New York

This Registration Rights Agreement (the “Agreement”) is made and entered into as of this 1st day of December, 2011 by and among Celsion Corporation, a Delaware corporation (the “Company”), and the Investors named in that certain Purchase Agreement by and among the Company and the Investors dated as of December 1, 2011 (the “Purchase Agreement”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!